Nascent Biotech
is a California-based clinical-stage biotechnology company that develops and commercializes monoclonal antibodies for the treatment of cancer... Read moreNascent Biotech
is a California-based clinical-stage biotechnology company that develops and commercializes monoclonal antibodies for the treatment of cancer... Read more
News
Jan 21, 2025
GlobeNewswire
Press Release: Nascent Biotech : Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing
Aug 08, 2024
Owler
Nascent Biotech, Inc.: Nascent Biotech's employee count had no change from Mar 2023 to Jun 2024
Jul 30, 2024
FinanzNachrichten
Nascent Biotech: Nascent Biotech, Inc.: Nascent Biotech Presents at the July Emerging Growth Conference
Jul 01, 2024
Marketscreener
Nascent Biotech: Nascent Biotech, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
Apr 16, 2024
FinanzNachrichten
Nascent Biotech: Nascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
Mar 21, 2024
Pharmabiz
Nascent Biotech: Nascent partners with HypoSpray to develop an alternative delivery mechanism for patients who can benefit from Pritumumab
Feb 14, 2024
Marketscreener
Nascent Biotech: Nascent Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Feb 08, 2024
Pharmabiz
Nascent Biotech: Nascent Biotech, Manhattan Bio collaborate to explore pritumumab antibodydrug conjugates
Dec 19, 2023
FinanzNachrichten
Nascent Biotech: Nascent Biotech Inc.: Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
Nov 29, 2023
FinanzNachrichten
Nascent Biotech: Nascent Biotech Inc.: Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
Nascent Biotech Competitors
1
2
3
4
5
6
7
8
9
10